<ul><li>Accenture has made a strategic investment in 1910 Genetics, a biotechnology company using AI-powered platform for drug discovery.</li><li>The collaboration aims to accelerate drug development, reduce costs, and deliver more effective therapies to patients.</li><li>1910 Genetics' ITO™ platform enhances target identification, molecule design, and simulations using AI.</li><li>Accenture's expertise will help integrate 1910 Genetics' AI platform into existing drug development pipelines.</li></ul>

Accenture Invests in 1910 Genetics to Accelerate AI-Powered Drug Discovery

Discover more